2Traversa et al. Cohort study of hepatotoxicity associated with nimesulide and other nonsteroidal anti -inflammatory drugs.BMJ, 2003, 327:18-22.
3Committee for proprietary medicinal products 22-24 JULY 2003 Plenary meeting monthly report 01. August 2003EMEA/ CPMP/37 54 /03.
4Committee for propriety medicinal products (CPMP)opinion following an article 31 referral. MAY. 2004. CPMP/1724/04.
5Altinkaynak,et al. Effect of nimesulide,rofecoxib and celecoxib on gastic tissue glutathione level in rats with indomethacin induced gastric ulcerations. Pol J Pharmacol,2003,55 :64.
6Macia MA, Carvajal A, del Pazo JG, et al. Hepatotoxicity associated with nimesulide data from the spanish pharmacocigilance system. Clin Pharmacol Ther. 2002,72:596-597.
7Nimesulide as safe as other NSAIDs. Scrip,2002,(2781) :24.
8WHO pharmaceuticals newsletter:Nimesulide-containing products for oral use-marketing suspended in Ireland due to reports of liver failure[EB/OL].2007-05-21.[2007-08-13].http://www.who.int.
3SEAN C S,主编.李大魁,金有豫,汤光等译.马丁代尔药物大典(原著第35版)[M].北京:化学工业出版社,2009:28-75.
4MARY A K K,LLOYD Y Y,WAYNE A K.临床药物治疗学[M].北京:人民卫生出版社,2007:32.
5Berson A, Cazanave S, Descatoire V, et al. The anti-inflammatory drug, nimesulide (4-nitro-2-phenoxymethanesulfoanilide), uncouples mitochondria and induces mitochondrial permeability transition in human hepatoma cells: protection by albumin[J]. J Pharmacol Exp Ther, 2006,318(1) : 444.
6Bartlett D. Acetaminophen toxicity[J]. J Emerg Nurse, 2004,30(3) :281.
7Thabah MM, Singh KK, Madhavan SM, et al.Adult onset Still' s disease as a cause of acute liver failure[J]. Trop Gastroenterol, 2008, 29(1) : 35.
8McClain C J, Price S, Barve S, et al.Acetaminophen hepatotoxicity: An update[J]. Curr Gastroenterol Rep, 1999,1 (1): 42.
9Moling O, Cairon E, Rimenti G, et al. Severe hepatotoxicity after therapeutic doses of acetaminophen[J]. Clin Ther,2006,28(5) : 755.
10Sbeit W, Krivoy N, Shiller M, et al. Nimesulide-induced acute hepatitis[J]. Ann Pharmacother, 2001,35 ( 9 ) : 1 049.
